This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Momenta Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: William Denney and His Patent in Myasthenia Gravis Treatment.
Introduction
William Denney is an inventor associated with Watertown, Massachusetts, and Momenta Pharmaceuticals, Inc. His patent work concerns antibody-based approaches to treating myasthenia gravis.
Latest Patents
The supplied information lists one patent associated with Denney: “Anti-FcRn Antibodies and Methods for Treating Myasthenia Gravis.” The patent describes antibodies targeting the neonatal Fc receptor (FcRn) and methods for using them in the treatment of myasthenia gravis. Denney is credited with 1 patent.
Career Highlights
Denney’s listed patent connects his work with pharmaceutical research and the development of potential treatments for autoimmune disease. The supplied information identifies Momenta Pharmaceuticals, Inc. as his company affiliation.
Collaborations
The supplied information names Sindhu Ramchandren and Hong Sun as Denney’s coworkers. Their shared association reflects the collaborative environment in which pharmaceutical research and patent development take place.
Conclusion
William Denney’s listed invention focuses on anti-FcRn antibodies and their potential use in treating myasthenia gravis, representing his documented contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile